research days

the brain foundation, a 501c3 non-profit presents

synchrony 2019

International Symposium on Translational Research in Autism

Nov.8-10 Pleasanton, California

attend live or streaming

research days, november 8-9

Researchers will present on key topics in autism research, followed by research round tables. The round tables represent collaboration between researchers, clinicians and parent advocates to identify the multi-disciplinary research agenda required to address key issues in ASD. Attendance at the round tables is by invitation but the research talks are open to medical professionals and are free to them. To attend, register for free below.

november 8

OVERVIEW OF RESEARCH DAYS   

 8:30 – 8:35

Welcome and Introduction to Brain

Sarika Agrawal

Secretary & Board Member 

GUT-IMMUNE-BRAIN AXIS, MITOCHONDRIA & METABOLISM

8:40 – 9:20

Gut-Brain Axis in Neurologic Disorders

Sarkis Mazmanian, PhD
Luis and Nelly Soux Professor of Microbiology, Caltech


9:25 – 10:05

Mitochondria in ASD: Oxidative Stress, Toxicant Exposure, GT Metabolites & Immunity

Richard Frye, MD PhD 

Chief, Neurodevelopmental Disorders,  Phoenix Children’s Hospital; Professor of Neurology, University of Arizona 


10:10 – 10:50

Molecular Mechanisms of GI Pathology in ASD

Arthur Krigsman, MD,

Pediatric Gastroenterology Resources

Stephen Walker, PhD,

Professor, Institute for Regenerative Medicine, Wake Forest


10:55 – 11:25

Overview of BRAIN Foundation

Pramila Srinivasan, Founder & President

Gita Gupta, VP Research & Board Member

Introduction to BRAIN & BRAIN Community, Goals and Overview of  Research Days & Research Round tables 


11:30 – 12:00

Innate Immunity & Inflammatory Subtype of ASD

Harumi Jyonouchi, MD
Associate Professor, Division of Allergy, Immunology & Rheumatology, School of Medicine, Rutgers University 

12:00 PM – 1:30 PM ROUNDTABLE – ER PROTOCOLS IN ASD (BY INVITATION)

12:00 – 1:30

 LUNCH FOR ALL ATTENDEES


 1:30  – 2:10

Linking Complex ASD Phenotypes to GI Issues

Ruth Ann Luna, PhD, MB(ASCP)
Director, Medical Metagenomics, Texas Children’s Microbiome Center, Texas Children’s Hospital

PRECISION MEDICINE IN ASD 

2:15 – 2:40

Clinical Whole Genome Sequence in ASD

David Bick, MD 

CMO, Hudson Alpha Biotechnology Center 


2:45 – 3:15

Developing Interventions Through Endophenotyping & Precision Medicine in ASD

Lynn Durham, CEO, STALICLA

NEUROBEHAVIORAL EXACERBATIONS IN ASD

3:15 – 3:30

Imperative for Discussing Neurobehavioral Exacerbations in ASD

Clinician & BRAIN Community Panel


 3:30 – 4:00

Antibody Associated Encephalitis

Samuel Pleasure, MD PhD
Glenn W. Johnson, Jr. Memorial Endowed Professor

Department of Neurology, UCSF  


4:00 – 4:30

Infectious & Post-Infectious Encephalitis

Michael Wilson, MD 

Associate Professor, Neurology, UCSF Weill Institute  


 4:30 – 4:50

Microbial effects of Immunity & Role in Neurobehavioral Exacerbations

Madeline Cunningham, PhD 

George Lynn Cross Research Professor, Microbiology & Immunology, University of Oklahoma School of Medicine 


5:00

DINNER FOR ROUND TABLE ATTENDEES  (BY INVITATION) 


november 9

 8:30 – 9:00

Corticostriatal Circuit Defects in a Mouse Model of Repetitive Behaviors

Naveen Nagarajan, PhD 

Post-Doctoral Fellow, Mario Capecchi Lab

Department of Human Genetics, University of Utah 


9:05 – 9:35

Metabolic Causes of Neurobehavioral Exacerbations in ASD

Richard Frye, MD PhD  

NEUROBEHAVIORAL EXACERBATIONS IN ASD

 9:40 – 10:40

Review of Pediatric Acute Onset Neuropsychiatric Syndrome (PANS) & New Research Findings

Margo Thienemann, MD
Clinical Professor, Psychiatry & Behavioral Sciences 

Co-Director PANS Clinic, Stanford University

Jennifer Frankovich, MD 

Associate Clinical Professor, Department of Pediatrics
Allergy, Immunology Rheumatology, Stanford University

Theresa Willetts, MD PhD 

Clinical Assistant Professor, Pediatrics – Immunology & Allergy

Jill Hollenbach, PhD

Associate Professor, Neurology
UCSF Weill Institute for Neurosciences

Shamma Rahman, PhD,

Post Doctoral Fellow, Human Gene Therapy, Mellins Lab,  Stanford

MEDICAL COMORBIDITIES IN ASD 

10:45 – 11:05

Overview of Medical Comorbidities in ASD

Daniel Rossignol, MD 

Rossignol Medical Center 


10:45 – 11:05

Overview of Medical Comorbidities in ASD

Daniel Rossignol, MD 

Rossignol Medical Center 


11:10 – 11:25

Utility of Lumbar Picture for Investigation of Metabolic Disorders in ASD

Deborah Renaud, MD

Consultant in Neurology & Genetics, Mayo Clinic


 11:30 – 11:45

Case Study – Behavioral Improvements From Treating Comorbidities

Agnieszka Wroczyńska, MD PhD,

Medical University of Gdansk & Polish Institute of Evidence Based Medicine

TECH INNOVATIONS TO SUPPORT PRECISION MEDICINE

11:45 – 12:00

Siteless Trials

Pramila Srinivasan, PhD, CEO, Medical Mine


12:00 – 12:30 

Autism Registry & Multiomics – Ready Biobank

Richard Frye, MD PhD 

ROUND TABLES 12:45 – 5:15 (BY INVITATION)

12:45 – 2:15

Neurobehavioral Exacerbations in ASD


2:15 – 3:45

Standard of Care in ASD


3:45 – 5:15

Tech Innovations


5:30

DINNER (TICKETS AVAILABLE FOR $1000)

6 PM STARTUP SPOTLIGHT (AT  DINNER)

Antipurinergic therapy for core disabilities of ASD
Stage:
Series A Company 


Direct-to-consumer DNA tests for rare disease diagnosis

Stage: Seed  


Metabolic biomarkers for early diagnosis of ASD 

Stage: Seed 


Precision medicine & drug discovery for ASD

Stage: Series A


research participants and speakers 

research round tables

*for medical professionals only


%d bloggers like this: